ANDA Filers Must Overcome Copyright Issues On “Unusual” Labeling – FDA Lawyer
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite a court decision holding that liability for copyright violation cannot attach to a generic company if it results from complying with Waxman/Hatch, copyright issues may arise in cases where brand labeling takes “unusual” forms, FDA Associate Chief Counsel Dickinson says.